Antifungal Susceptibility Testing - The Times They Are a Changin'

Antifungal susceptibility testing (AFST) has never been as mainstream as antibacterial susceptibility testing. That may soon change. We are in an unprecedented era of antifungal development which could change the usefulness of and demand for AFST. Here we lay out an argument for increased AFST capacity, discuss new antifungals that are likely to appear on the market in the next few years, discuss the phenomenon trailing growth in Candida that can lead to false interpretation of susceptibility results, and discuss some of the problems encountered during AFST and how to manage them.